Q1 2014 13F Holders as of 3/31/2014
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
4
-
Total 13F shares, excl. options
-
353K
-
Shares change
-
+3.1K
-
Total reported value, excl. options
-
$276K
-
Value change
-
-$5.62K
-
Number of buys
-
3
-
Number of sells
-
-1
-
Price
-
$0.78
Significant Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q1 2014
5 filings reported holding IGC - IGC Pharma, Inc. - COM NEW as of Q1 2014.
IGC Pharma, Inc. - COM NEW (IGC) has 4 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 353K shares
.
Largest 5 shareholders include WELLS FARGO & COMPANY/MN (293K shares), Citadel Advisors LLC (42.7K shares), Creative Planning (14.2K shares), UBS AG (2.9K shares), and KCG HOLDINGS, INC. (0 shares).
This table shows the top 4 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.